List of Laurus Labs patents

Patents where

Current Assignee

Name

Laurus Labs

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11318116 Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof	Patent 11318116 was granted and assigned to Laurus Labs on May, 2022 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11318116	May 3, 2022
‌ US Patent 10428053 Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof	Patent 10428053 was granted and assigned to Laurus Labs on October, 2019 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	10428053	October 1, 2019
‌ US Patent 11345685 Process and crystalline forms of lumacaftor	Patent 11345685 was granted and assigned to Laurus Labs on May, 2022 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11345685	May 31, 2022
‌ US Patent 11345684 Process and crystalline forms of Lumacaftor	Patent 11345684 was granted and assigned to Laurus Labs on May, 2022 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11345684	May 31, 2022
‌ US Patent 11040961 Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof	Patent 11040961 was granted and assigned to Laurus Labs on June, 2021 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11040961	June 22, 2021
‌ US Patent 11427570 Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof	Patent 11427570 was granted and assigned to Laurus Labs on August, 2022 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11427570	August 30, 2022
‌ US Patent 11634431 Process for purification of protected polycyclic carbamoylpyridone derivatives	Patent 11634431 was granted and assigned to Laurus Labs on April, 2023 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11634431	April 25, 2023
‌ US Patent 11434196 Process for preparation of 2-Amino-5-hydroxy propiophenone		Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11434196	September 6, 2022
‌ US Patent 11414386 Process for the preparation of ivacaftor and its intermediates		Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11414386	August 16, 2022
‌ US Patent 11066368 Process for the preparation and particle size reduction of pirfenidone	Patent 11066368 was granted and assigned to Laurus Labs on July, 2021 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11066368	July 20, 2021
‌ US Patent 9487487 Process for preparation of montelukast sodium	Patent 9487487 was granted and assigned to Laurus Labs on November, 2016 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	9487487	November 8, 2016
‌ US Patent 9957234 Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereof	Patent 9957234 was granted and assigned to Laurus Labs on May, 2018 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	9957234	May 1, 2018
‌ US Patent 11053220 Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline	Patent 11053220 was granted and assigned to Laurus Labs on July, 2021 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11053220	July 6, 2021
‌ US Patent 9475821 Process for preparation of Darunavir	Patent 9475821 was granted and assigned to Laurus Labs on October, 2016 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	9475821	October 25, 2016
‌ US Patent 9382207 Process for the preparation of atazanavir bisulfate	Patent 9382207 was granted and assigned to Laurus Labs on July, 2016 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	9382207	July 5, 2016
‌ US Patent 8987525 Process for the preparation of polyhydroxystilbene compounds by deprotection of the corresponding ethers	Patent 8987525 was granted and assigned to Laurus Labs on March, 2015 by the United States Patent and Trademark Office.		Laurus Labs	United States Patent and Trademark Office	8987525	March 24, 2015
‌ US Patent 9567292 Process for preparation of 2,3-dihydroxy benzonitrile	Patent 9567292 was granted and assigned to Laurus Labs on February, 2017 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	9567292	February 14, 2017
‌ US Patent 8207343 Process for preparing montelukast and salts thereof	Patent 8207343 was granted and assigned to Laurus Labs on June, 2012 by the United States Patent and Trademark Office.		Laurus Labs	United States Patent and Trademark Office	8207343	June 26, 2012
‌ US Patent 10738038 Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof		Laurus Labs	Laurus Labs	United States Patent and Trademark Office	10738038	August 11, 2020
‌ US Patent 9573902 Process for the preparation of Ivacaftor and its intermediates	Patent 9573902 was granted and assigned to Laurus Labs on February, 2017 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	9573902	February 21, 2017
‌ US Patent 9181256 Salts of sitagliptin, process for the preparation and pharmaceutical composition therefore	Patent 9181256 was granted and assigned to Laurus Labs on November, 2015 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	9181256	November 10, 2015
‌ US Patent 10836753 Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof	Patent 10836753 was granted and assigned to Laurus Labs on November, 2020 by the United States Patent and Trademark Office.	Laurus Labs	Laurus Labs	United States Patent and Trademark Office	10836753	November 17, 2020
‌ US Patent 11427555 Processes for preparation of dapagliflozin or its solvates or co-crystals thereof		Laurus Labs	Laurus Labs	United States Patent and Trademark Office	11427555	August 30, 2022
‌ US Patent 10654872 Polymorphs of dolutegravir and salts thereof		Laurus Labs	Laurus Labs	United States Patent and Trademark Office	10654872	May 19, 2020
‌ US Patent 10647729 Polymorphs of dolutegravir and salts thereof		Laurus Labs	Laurus Labs	United States Patent and Trademark Office	10647729	May 12, 2020

Results per page:

42 results

0 selected

42 results

0 selected